Additionally, we found that while elevated levels of PIM1 contribute resistance to ADT, the combination of a pan‐PIM‐i and H19 KD can reduce the tumor‐forming capacity of highly aggressive NEPC. This evidence concerns the gene PIM1 and neoplasm.